Regulatory and ESG Policy Outlook for Biopharma

Update on global hard and soft regulatory changes affecting biopharma.
Focus on EU: Green Deal, Circular Economy, Sustainable Finance, Non-Financial Reporting Directive.
Speaker: Olivier Jaeggi, Managing Director, ECO:FACT